Gene expression in colorectal liver metastasis tissues from EPA-treated patients
Ontology highlight
ABSTRACT: Eicosapentaenoic acid in its free fatty acid form (EPA-FFA), 2g daily, is safe and well-tolerated in patients undergoing liver resection surgery for colorectal liver metastasis.Oral EPA incorporates into colorectal liver metastasis tissue. EPA-FFA treatment is associated with reduced vascularity of liver metastases in ω-3 PUFA-naïve patients. Preoperative (median 30 days) EPA-FFA treatment may have prolonged benefit on postoperative overall and disease-free survival. We used whole genome expression array to study whether systemic CCL2 level changes were linked to a specific tumour gene expression profile in colorectal liver metastasis patients treated with EPA-FFA.
ORGANISM(S): Homo sapiens
PROVIDER: GSE79266 | GEO | 2016/03/16
SECONDARY ACCESSION(S): PRJNA315304
REPOSITORIES: GEO
ACCESS DATA